Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT07743476

Conditions

Hematologic

Bone Marrow

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

data collection

Study Details

Brief summary:

To create a registry for people who are undergoing or previously underwent radiotherapy for hematologic or related disorders.

Conditions

Hematologic

Bone Marrow

Study ID

NCT07743476

Start date

Aug 31, 2026

Status verified date

Sep, 2026

Completion date

Dec 31, 2038

Anticipated

Primary completion date

Dec 31, 2036

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria

  • Undergoing or previously underwent radiotherapy at The University of Texas MD Anderson Cancer Center for hematologic or related disorders.
  • Available clinical, imaging, laboratory, treatment, and/or outcome data relevant to study objectives.
  • Ability to provide informed consent for prospective participation, when applicable.

Exclusion Criteria

Participants meeting any of the following criteria will be excluded:

  • Inability to provide informed consent, or when applicable, the absence of a legally authorized representative able to provide consent for prospective participation.
  • Insufficient clinical information available to support study objectives.
  • Pregnant women

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Interventions

data collection

The study will collect clinical, imaging, laboratory, treatment, and outcome data from the electronic medical record, radiation treatment planning systems, imaging archives, and other institutional clinical databases

Primary outcome measure

  • Safety and adverse events (AEs). [ Time Frame: Through study completion; an average of 1 year. ]

Central Contacts and Locations

Central contacts

Omran Saifi, MD

832-829-0337OSaifi@mdanderson.org

Locations

UT MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Omran Saifi, MD

832-829-0337OSaifi@mdanderson.org

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Sep 8, 2026

Last verified

Sep, 2026

Keywords

  • Quantitative Marrow Imaging
  • Marrow Reserve
  • Radiotherapy

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-09-08.